Resultats de la cerca - Müller‐Tidow, Carsten

Refinar resultats
  1. 1
    Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia

    Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia per Göllner, Stefanie, Müller-Tidow, Carsten

    Publicat 2017
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  2. 2
    The Indications for Allogeneic Stem Cell Transplantation in Myeloid Malignancies

    The Indications for Allogeneic Stem Cell Transplantation in Myeloid Malignancies per Müller, Lutz P, Müller-Tidow, Carsten

    Publicat 2015
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  3. 3
    The limited contribution of DNA methylation to PML-RARα induced leukemia

    The limited contribution of DNA methylation to PML-RARα induced leukemia per Rohde, Christian, Schoofs, Till, Müller-Tidow, Carsten

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  4. 4
    Improving consolidation therapy in acute myeloid leukemia - a tough nut to crack

    Improving consolidation therapy in acute myeloid leukemia - a tough nut to crack per Schlenk, Richard F., Jaramillo, Sonia, Müller-Tidow, Carsten

    Publicat 2018
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  5. 5
    AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

    AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting per Wünsch, Christian, Banck, Henrik, Müller-Tidow, Carsten, Dugas, Martin

    Publicat 2020
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  6. 6
    Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML

    Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML per BANCK, HENRIK, DUGAS, MARTIN, MÜLLER-TIDOW, CARSTEN, SANDMANN, SARAH

    Publicat 2021
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  7. 7
    Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study

    Workflow to improve patient recruitment for clinical trials within hospital information systems – a case-study per Dugas, Martin, Lange, Matthias, Berdel, Wolfgang E, Müller-Tidow, Carsten

    Publicat 2008
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  8. 8
    Characterization of the Ca(2+)-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration

    Characterization of the Ca(2+)-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration per Austermann, Judith, Nazmi, Ali Reza, Müller-Tidow, Carsten, Gerke, Volker

    Publicat 2008
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  9. 9
    The Treatment of Elderly Patients With Acute Myeloid Leukemia

    The Treatment of Elderly Patients With Acute Myeloid Leukemia per Krug, Utz, Büchner, Thomas, Berdel, Wolfgang E, Müller-Tidow, Carsten

    Publicat 2011
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  10. 10
    HIS-based Kaplan-Meier plots - a single source approach for documenting and reusing routine survival information

    HIS-based Kaplan-Meier plots - a single source approach for documenting and reusing routine survival information per Breil, Bernhard, Semjonow, Axel, Müller-Tidow, Carsten, Fritz, Fleur, Dugas, Martin

    Publicat 2011
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  11. 11
    Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation

    Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation per Korell, Felix, Schreck, Nicholas, Müller-Tidow, Carsten, Dreger, Peter, Luft, Thomas

    Publicat 2022
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  12. 12
    Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia

    Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia per Wass, Maxi, Hitz, Friederike, Schaffrath, Judith, Müller-Tidow, Carsten, Müller, Lutz P.

    Publicat 2016
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  13. 13
    DDX41-related myeloid neoplasia

    DDX41-related myeloid neoplasia per Maciejewski, Jaroslaw P., Padgett, Richard A., Brown, Anna L., Müller-Tidow, Carsten

    Publicat 2017
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  14. 14
    Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment

    Prognostic factors of resected node-positive lung cancer: location, extent of nodal metastases, and multimodal treatment per Marra, Alessandro, Richardsen, Gunther, Wagner, Wolfgang, Müller-Tidow, Carsten, Koch, Olaf M., Hillejan, Ludger

    Publicat 2011
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  15. 15
    Hematological Malignancies in Adults With a Family Predisposition

    Hematological Malignancies in Adults With a Family Predisposition per Bochtler, Tilmann, Haag, Georg-Martin, Schott, Sarah, Kloor, Matthias, Krämer, Alwin, Müller-Tidow, Carsten

    Publicat 2018
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  16. 16
    Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity

    Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity per Schaffrath, Judith, Schmoll, Hans-Joachim, Voigt, Wieland, Müller, Lutz P., Müller-Tidow, Carsten, Mueller, Thomas

    Publicat 2017
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  17. 17
    Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants

    Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants per Restle, Anja, Färber, Martin, Baumann, Cindy, Böhringer, Michael, Scheidtmann, Karl Heinz, Müller-Tidow, Carsten, Wiesmüller, Lisa

    Publicat 2008
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  18. 18
    The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects

    The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects per Zhang, Feng, Bäumer, Nicole, Rode, Miriam, Ji, Ping, Zhang, Tao, Berdel, Wolfgang E., Müller-Tidow, Carsten

    Publicat 2011
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  19. 19
    A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis

    A Limited Role for the Cell Cycle Regulator Cyclin A1 in Murine Leukemogenesis per Bäumer, Nicole, Bäumer, Sebastian, Haak, Miriam, Koschmieder, Steffen, Schönig, Kai, Berdel, Wolfgang E., Müller-Tidow, Carsten

    Publicat 2015
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  20. 20
    BCR-ABL(+) acute myeloid leukemia: are we always dealing with a high-risk disease?

    BCR-ABL(+) acute myeloid leukemia: are we always dealing with a high-risk disease? per Neuendorff, Nina Rosa, Hemmati, Philipp, Arnold, Renate, Ihlow, Jana, Dörken, Bernd, Müller-Tidow, Carsten, Westermann, Jörg

    Publicat 2018
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:

Eines de cerca: